<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>50</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Rare Cytogenetic Presentation of Acute Myeloid Leukemia (AML-M2)</title>
    <FirstPage>827</FirstPage>
    <LastPage>830</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Prasanna</FirstName>
        <LastName>Kumari</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Bidadi</FirstName>
        <LastName>LingappaKavitha</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Chintaparthi Obula</FirstName>
        <LastName>Reddy</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Maiana</FirstName>
        <LastName>Mangalagowri</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Danem Satienariana</FirstName>
        <LastName>Madhumathi</LastName>
        <affiliation locale="en_US">Department of Pathology, Hematology Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Madaiah Mahadeva</FirstName>
        <LastName>Prasad</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Hanumanthappa Vijay</FirstName>
        <LastName>Raghavendra</LastName>
        <affiliation locale="en_US">Department of Pathology, Hematology Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Chennagiri Shinivasa</FirstName>
        <LastName>Murthy Premalata</LastName>
        <affiliation locale="en_US">Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Kuntejowdahalli Channaviriappa</FirstName>
        <LastName>Lakshmaiah</LastName>
        <affiliation locale="en_US">Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, 560029, India.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Hashem</FirstName>
        <LastName>Mir Mazloumi</LastName>
        <affiliation locale="en_US">Department of Pathology, Cytogenetic Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Acute myeloid leukemia (AML) with t(8;21)(q22;q22) generating the AML1/ETO fusion gene on 8q22 is a distinct type of AML t(8;21) category (WHO)/AML-M2 (FAB), generally associated with a favourable prognosis. Variant additional chromosomal abnormalities are frequently reported. We report three adult cases of this category with unusual karyotype. Bone marrow cytogenetics of case no. 1: 45,X,-Y, t(8;21)(q13;q22) with a novel breakpoint of chromosome 8 at (q13). Case no. 2: 46,X,t(X;2)(q22;q37),t(3;7)(q21;q36),t(5;14)(p15;q11),del(8)(q22) a complex rearrangement without the involvement of chromosome 21. Case no. 3: 49,XX,+5, t(8;21)(q22;q22), +16, +der(21)t(8;21)(q22;q22) with additional der(21). Endometrial in this case which was positive for myeloperoxidase (MPO) and CD117 conforming the AML infiltration. All are morphologically AML with t(8;21). Relevant literature in cytogenetic of AML-M2 is reviewed. The molecular mechanism involved in unusual rearrangements and clinical significance of them are subjected for further studies.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4002</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4002/3977</pdf_url>
  </Article>
</Articles>
